• Politics
  • Diversity, equity and inclusion
  • Financial Decision Making
  • Telehealth
  • Patient Experience
  • Leadership
  • Point of Care Tools
  • Product Solutions
  • Management
  • Technology
  • Healthcare Transformation
  • Data + Technology
  • Safer Hospitals
  • Business
  • Providers in Practice
  • Mergers and Acquisitions
  • AI & Data Analytics
  • Cybersecurity
  • Interoperability & EHRs
  • Medical Devices
  • Pop Health Tech
  • Precision Medicine
  • Virtual Care
  • Health equity

iReceptor Bags $9.6M in International Funding for Data Sharing Platform


The platform will enable researchers around the world to analyze and share immunological datasets.

This image has been resized. Courtesy of www.ireceptor-plus.com.

The iReceptor Plus consortium, which is composed of more than 20 partners from nine countries, was granted approximately $9.6 million by the European Union and the Canadian government to promote human immunological data storage, integration and controlled sharing for clinical and scientific purposes, according to the company.

The four-year project, headed by Bar-Ilan University in Ramat Gan, Israel, will expand the iReceptor platform that was developed with more than $1.9 million in funding from the Canadian government. The platform integrates distributed repositories of Adaptive Immune Receptor Repertoire sequence data, characterizing antibodies and T-cell receptors from large quantities of immune cells.

>> READ: FDA Recognizes First Ever Public Database for Genetic Variants

According to the company, the platform will enhance data security, add analysis tools and integrate Adaptive Immune Receptor Repertoire sequence data with other data to offer an advanced immune-profiling hub.

“iReceptor Plus will advance the understanding of immune responses, and thus provide new targets for therapies and new methods for monitoring therapeutic efficacy,” said Gur Yaari, coordinator of the iReceptor Plus project and associate professor at the Alexander Kofkin Faculty of Engineering at Bar-Ilan University.

The integration of Adaptive Immune Receptor Repertoire sequence data will facilitate the analysis and international sharing of the data across labs, diseases and institutions.

“iReceptor Plus will improve our ability to share and compare (Adaptive Immune Receptor Repertoire sequence) data and will also promote the discovery of biomedical interventions that manipulate the adaptive immune system, such as vaccines and other immunotherapies,” said Felix Breden, lead scientist for iReceptor’s initial development and scientific manager of the current project.

Database nodes of the iReceptor Plus network will be established at multiple international sites.

Funding was led by the European Union through the Horizon 2020 Research and Innovation Programme, which contributed about $8.9 million.

Get the best insights in healthcare analytics directly to your inbox.


Health Tech Kicks Off 2019 with $119M in Funding

5 Emerging Technologies that Will Change Healthcare

What’s Next for Cybersecurity in 2019?

Related Videos
Image: Ron Southwick, Chief Healthcare Executive
George Van Antwerp, MBA
Edmondo Robinson, MD
Craig Newman
Related Content
© 2024 MJH Life Sciences

All rights reserved.